Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Schmitz C et al. | 2004 | animal, mouse/Han:NMRI, whole body | magnetic field, 50/60 Hz | 1.8 mT |
Shi Z | 2019 | - | magnetic field, 50/60 Hz | - |
Shibaki R et al. | 2022 | intact cell/cell culture, MES-SA and MES-SA/DxS cells (human uterine sarcoma cell lines) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Simko M et al. | 2001 | intact cell/cell culture, macrophages (mouse) | magnetic field, low frequency, 50/60 Hz | 1.5 mT |
Sołek P et al. | 2022 | intact cell/cell culture, HeLa cells (human adenocarcinoma cell line) and DU 145 cells (human prostate cancer cell line) | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Stevenson AP et al. | 1985 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | electric field, magnetic field, 50/60 Hz | 50–800 µT |
Strasak L et al. | 2002 | bacterium, <i>Escherichia coli</i> | magnetic field, 50/60 Hz | 2.7–10 mT |
Su L et al. | 2017 | intact cell/cell culture, U251 and A127 (human glioblastoma cell lines), SH-SY5Y (human neuroblastoma cell line), rat astrocytes, rat microglia, primary cortical neurons (of rat) | magnetic field, low frequency, 50/60 Hz | 2 mT |
Sun W et al. | 2008 | intact cell/cell culture, FL cells (human amniotic cells) | magnetic field, low frequency, 50/60 Hz | 0.05–0.4 mT |
Tabrah FL et al. | 1978 | intact cell/cell culture, ciliate/slipper animalcule (<i>Tetrahymena pyriformis</i>) | magnetic field, 50/60 Hz | 6–10 mT |
Takahashi M et al. | 2017 | - | magnetic field, 50/60 Hz | - |
Tao Q et al. | 1999 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Ubeda A et al. | 1995 | intact cell/cell culture, C3H 10T1/2 CL8 cells (derived from mouse embryo fibroblasts) | magnetic field, 50/60 Hz | 1.6 mT |
Valtersson U et al. | 1997 | intact cell/cell culture, CEM-CM3 (human acute lymphoblastic leukemia) cells and Jurkat cells (human lymphoblastoid T cells) | magnetic field, 50/60 Hz | 100 µT |
Volpe P et al. | 1998 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, 50/60 Hz | 45–70 µT |
Wang D et al. | 2018 | intact cell/cell culture, human cancer cell lines (HeLa, HCT116, MCF7, A549, and GIST-T1), rat cancer cell lines (differentiated PC12, undifferentiated PC12, and C6), non-cancer cell lines (RPE1, CHO, and 293T) | 50/60 Hz, static magnetic field, magnetic field | - |
Wang X et al. | 2008 | bacterium, <i>Magnetospirillum magneticum</i>/AMB-1 | magnetic field, geomagnetic field, 50/60 Hz | 0–1 mT |
Wang Z et al. | 2024 | intact cell/cell culture, RSC96 cells, animal, rat/Sprague Dawley | 50/60 Hz, magnetic field, signals/pulses, also other exposures without EMF, co-exposure | - |
Woods M et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 46–100 µT |
Wu J et al. | 2021 | bacterium, composting material including bacteria | magnetic field, 50/60 Hz | - |
Wu X et al. | 2014 | intact cell/cell culture, FL cells (human amniotic cells) | magnetic field, 50/60 Hz | 0.4 mT |
Yamaguchi DT et al. | 2002 | intact cell/cell culture, ROS 17/2.8 (osteoblast-like cells) and MC3T3-E1 cells (mouse osteoblast-like cells) | magnetic field, low frequency, 50/60 Hz, therapeutic/medical device | 0.6–1.25 mT |
Yan J et al. | 2010 | intact cell/cell culture, human mesenchymal stem cells | magnetic field, low frequency, 50/60 Hz | 20 mT |
Zhang J et al. | 2016 | bacterium, <i>alpha-hemolytic Streptococcus</i> H1S-33 | magnetic field, 50/60 Hz | 0.1–1.5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.